Davis E. Efficacy of Targeted mRNA Therapeutics in Refractory Autoimmune Disorders: A Phase II Clinical Trial. Med. Insights [Internet]. 2025 Nov. 17 [cited 2026 May 12];2(4):36-47. Available from: https://soapubs.com/index.php/MI/article/view/1836